Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancerKei Kudo, Nobuhiro Tanuma|FEBS Letters|2020Cited by 16
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancerKei Kudo, Christina M. Annunziata|Cancer Gene Therapy|2024Cited by 10
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Christina M. Annunziata|Cell Death and Disease|2025Cited by 3